Arteria met guidance for FY20 and posted targets for FY25 that are well-ahead of consensus expectations. Weakness earlier in the year re-set expectations but growth is coming back. We remain at Buy.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.